August 25, 2025Cancer Drug ResistanceOpen Access

New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancer

View Full Paper

Ask AI

Bookmark

Resistance to alk-targeted therapy poses significant challenges, complicating treatment for patients with lung cancer.
Key contributors to resistance include both on-target and off-target mechanisms, which are increasingly being understood.
The assessment of resistance mechanisms is necessary to develop effective treatment strategies for non-small cell lung cancer.
Improving knowledge on resistance presents opportunities for enhancing diagnosis and management of advanced ALK-positive lung cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Review highlights mechanisms of therapeutic resistance in ALK-positive lung cancer, suggesting new treatment strategies.

Long et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark